You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

NADOLOL - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for nadolol and what is the scope of freedom to operate?

Nadolol is the generic ingredient in two branded drugs marketed by Uswm, Alembic, Amneal Pharms Co, Aurobindo Pharma, Beximco Pharms Usa, Chartwell Rx, Heritage Pharma, Invagen Pharms, Novast Labs, Rising, Rk Pharma, Sandoz, Teva Pharms, and Zydus Pharms, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for nadolol. Sixteen suppliers are listed for this compound.

Drug Prices for NADOLOL

See drug prices for NADOLOL

Drug Sales Revenue Trends for NADOLOL

See drug sales revenues for NADOLOL

Recent Clinical Trials for NADOLOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Unity Health TorontoN/A
National Institute on Aging (NIA)Phase 4
The New York Community TrustPhase 4

See all NADOLOL clinical trials

Pharmacology for NADOLOL
Medical Subject Heading (MeSH) Categories for NADOLOL

US Patents and Regulatory Information for NADOLOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co NADOLOL nadolol TABLET;ORAL 208832-003 Jun 2, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms NADOLOL nadolol TABLET;ORAL 207761-003 Jul 28, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz NADOLOL nadolol TABLET;ORAL 074501-001 Nov 9, 1995 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novast Labs NADOLOL nadolol TABLET;ORAL 210786-001 Jun 1, 2018 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NADOLOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Uswm CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 ⤷  Sign Up ⤷  Sign Up
Uswm CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Uswm CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Uswm CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.